Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Bluebird Bio (BLUE)

Bluebird Bio (BLUE)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
5.25 +0.37 (+7.58%) 04/01/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 5.16 -0.09 (-1.71%) 18:52 ET
Quote Overview for Tue, Apr 1st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
4.82
Day High
5.37
Open 4.86
Previous Close 4.88 4.88
Volume 860,000 860,000
Avg Vol 516,295 516,295
Stochastic %K 71.67% 71.67%
Weighted Alpha -65.83 -65.83
5-Day Change +1.40 (+36.36%) +1.40 (+36.36%)
52-Week Range 3.56 - 28.60 3.56 - 28.60
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 47,776
  • Shares Outstanding, K 9,790
  • Annual Sales, $ 83,810 K
  • Annual Income, $ -240,720 K
  • EBIT $ -270 M
  • EBITDA $ -209 M
  • 60-Month Beta 0.77
  • Price/Sales 0.00
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 128.21% ( -6.21%)
  • Historical Volatility 173.48%
  • IV Percentile 46%
  • IV Rank 16.85%
  • IV High 697.81% on 10/14/24
  • IV Low 12.81% on 12/17/24
  • Put/Call Vol Ratio 1.92
  • Today's Volume 869
  • Volume Avg (30-Day) 871
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 94,609
  • Open Int (30-Day) 89,768

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -3.60
  • Number of Estimates 1
  • High Estimate -3.60
  • Low Estimate -3.60
  • Prior Year -7.20
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.65 +43.84%
on 03/27/25
Period Open: 4.08
5.42 -3.14%
on 03/31/25
+1.17 (+28.68%)
since 02/28/25
3-Month
3.56 +47.47%
on 02/24/25
Period Open: 8.34
10.28 -48.91%
on 01/06/25
-3.09 (-37.05%)
since 12/31/24
52-Week
3.56 +47.47%
on 02/24/25
Period Open: 24.80
28.60 -81.64%
on 07/16/24
-19.55 (-78.83%)
since 04/01/24

Most Recent Stories

More News
Stocks Set to Open Sharply Lower as Tariff Worries Sour Risk Sentiment, U.S. Jobs Data and Powell’s Remarks Awaited

June S&P 500 E-Mini futures (ESM25) are down -1.01%, and June Nasdaq 100 E-Mini futures (NQM25) are down -1.21% this morning as risk sentiment took a hit ahead of U.S. President Donald Trump’s deadline...

GOOGL : 157.07 (+1.57%)
NVDA : 110.15 (+1.63%)
PVH : 76.43 (+18.24%)
OXM : 59.35 (+1.16%)
BLUE : 5.25 (+7.58%)
WRB : 70.25 (-1.28%)
ABF.LN : 1,927.000 (+0.89%)
CAG : 26.60 (-0.26%)
LW : 53.31 (+0.02%)
ESM25 : 5,665.00 (-0.17%)
LULU : 279.63 (-1.21%)
COOP : 125.08 (+4.58%)
Bluebird: Q3 Earnings Snapshot

Bluebird: Q3 Earnings Snapshot

BLUE : 5.25 (+7.58%)
Bluebird: Q2 Earnings Snapshot

Bluebird: Q2 Earnings Snapshot

BLUE : 5.25 (+7.58%)
Bluebird: Q1 Earnings Snapshot

Bluebird: Q1 Earnings Snapshot

BLUE : 5.25 (+7.58%)
Is Bluebird Bio Stock a Buy?

It won't be easy for the company to bounce back.

BLUE : 5.25 (+7.58%)
Is Bluebird Bio Stock a Buy?

This small biotech is struggling to fly -- and investors should probably steer clear.

BLUE : 5.25 (+7.58%)
Better Buy: Bluebird Bio Vs. Novavax

Who wins this face-to-face between two beaten-down biotechs?

BLUE : 5.25 (+7.58%)
NVAX : 6.00 (-6.40%)
Is This Beaten-Down Stock a Good Acquisition Target?

This company has proven its innovative abilities, but that's not enough to outperform the market.

BLUE : 5.25 (+7.58%)
Bluebird Bio Stock Has 138% Upside, According to 1 Wall Street Analyst

Biotech stocks are famously volatile. One analyst feels this one could be volatile enough to produce an outsized gain.

WFC : 71.31 (-0.67%)
BLUE : 5.25 (+7.58%)
Why Bluebird Bio Stock Flew Higher Than the Market Today

The company was thrown a financial lifeline.

HTGC : 19.10 (-0.57%)
BLUE : 5.25 (+7.58%)

Business Summary

bluebird bio, Inc. is a clinical-stage biotechnology that is focused on developing gene therapies for severe genetic diseases and cancer. The company has developed a deep pipeline using lentiviral-based gene therapies, T-cell immunotherapy expertise, and gene editing capabilities to treat severe genetic...

See More

Key Turning Points

3rd Resistance Point 6.03
2nd Resistance Point 5.70
1st Resistance Point 5.47
Last Price 5.25
1st Support Level 4.92
2nd Support Level 4.59
3rd Support Level 4.37

See More

52-Week High 28.60
Fibonacci 61.8% 19.03
Fibonacci 50% 16.08
Fibonacci 38.2% 13.13
Last Price 5.25
52-Week Low 3.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies